Influence of acetaminophen and ibuprofen on skeletal muscle adaptations to resistance exercise in older adults

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 300, Issue 3, 2011, Pages

  Trappe, Todd A ^a   Carroll, Chad C ^a   Dickinson, Jared M ^a   LeMoine, Jennifer K ^a   Haus, Jacob M ^a   Sullivan, Bridget E ^a   Lee, Jonah D ^a   Jemiolo, Bozena ^a   Weinheimer, Eileen M ^a   Hollon, Chris J ^a  

^a BALL STATE UNIVERSITY   (United States)

Author keywords

Cyclooxygenase; Prostaglandin; Sarcopenia

Indexed keywords

IBUPROFEN; MYOSIN HEAVY CHAIN; PARACETAMOL; PLACEBO; PROTEIN;

ADAPTATION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG USE; EXERCISE TOLERANCE; FEMALE; HAMSTRING; HUMAN; HUMAN EXPERIMENT; MALE; MUSCLE BIOPSY; MUSCLE HYPERTROPHY; MUSCLE MASS; MUSCLE STRENGTH; NORMAL HUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROTEIN CONTENT; RANDOMIZED CONTROLLED TRIAL; RESISTANCE TRAINING; SKELETAL MUSCLE; VASTUS LATERALIS MUSCLE; WATER CONTENT;

ACETAMINOPHEN; ADAPTATION, PHYSIOLOGICAL; AGE FACTORS; AGED; BIOPSY; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; EXERCISE; FEMALE; HUMANS; IBUPROFEN; MALE; MIDDLE AGED; MUSCLE STRENGTH; MYOSIN HEAVY CHAINS; ORGAN SIZE; QUADRICEPS MUSCLE; RESISTANCE TRAINING; TIME FACTORS;

EID: 79954513012     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00611.2010     Document Type: Article

References (53)

1. Berg HE, Tedner B, Tesch PA. Changes in lower limb muscle crosssectional area and tissue fluid volume after transition from standing to supine. Acta Physiol Scand 148: 379-385, 1993.
2. Bergstrom J. Muscle electrolytes in man. Scand J Clin Lab Invest 14: 7-110, 1962.
3. Biolo G, Fleming RY, Maggi SP, Wolfe RR. Transmembrane transport and intracellular kinetics of amino acids in human skeletal muscle. Am J Physiol Endocrinol Metab 268: E75-E84, 1995.
4. Bondesen BA, Mills ST, Pavlath GK. The COX-2 pathway regulates growth of atrophied muscle via multiple mechanisms. Am J Physiol Cell Physiol 290: C1651-C1659, 2006.
5. Burd NA, Dickinson JM, Lemoine JK, Carroll CC, Sullivan BE, Haus JM, Jemiolo B, Trappe SW, Hughes GM, Sanders CE Jr, Trappe TA. Effect of a cyclooxygenase-2 inhibitor on postexercise muscle protein synthesis in humans. Am J Physiol Endocrinol Metab 298: E354-E361, 2010.
6. Carroll CC, Trappe TA. Personal digital video: a method to monitor drug regimen adherence during human clinical investigations. Clin Exp Pharmacol Physiol 33: 1125-1127, 2006.
7. Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS, Simmons DL. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA 99: 13926-13931, 2002.
8. Chandrasekharan NV, Simmons DL. The cyclooxygenases. Genome Biol 5: 241, 2004.
9. Chen YF, Jobanputra P, Barton P, Bryan S, Fry-Smith A, Harris G, Taylor RS. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. Health Technol Assess 12: 1-178, 2008.
10. Chi MY, Hintz CS, Coyle EF, Martin WH, Ivy JL, Nemeth PH, Holloszy JO, Lowry OH. Effects of detraining on enzymes of energy metabolism in individual human muscle fibers. Am J Physiol Cell Physiol 244: C276-C287, 1983.
11. Diaz A, Reginato AM, Jimenez SA. Alternative splicing of human prostaglandin G/H synthase mRNA and evidence of differential regulation of the resulting transcripts by transforming growth factor-β1, interleukin-1β, and tumor necrosis factor-α. J Biol Chem 267: 10816-10822, 1992.
12. Doherty TJ. Aging and sarcopenia. J Appl Physiol 95: 1717-1727, 2003.
13. Dutta C, Hadley EC, Lexell J. Sarcopenia and physical performance in old age: overview. Muscle Nerve Suppl 5: S5-S9, 1997.
14. Fiatarone MA, Marks EC, Ryan ND, Meredith CN, Lipsitz LA, Evans WJ. High-intensity strength training in nonagenarians. Effects on skeletal muscle. JAMA 263: 3029-3034, 1990.
15. Fiatarone MA, O'Neill EF, Ryan ND, Clements KM, Solares GR, Nelson ME, Roberts SB, Kehayias JJ, Lipsitz LA, Evans WJ. Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med 330: 1769-1775, 1994.
16. Frontera WR, Hughes VA, Fielding RA, Fiatarone MA, Evans WJ, Roubenoff R. Aging of skeletal muscle: a 12-yr longitudinal study. J Appl Physiol 88: 1321-1326, 2000.
17. Frontera WR, Meredith CN, O'Reilly KP, Knuttgen HG, Evans WJ. Strength conditioning in older men: skeletal muscle hypertrophy and improved function. J Appl Physiol 64: 1038-1044, 1988.
18. Giulian G, Moss RL, Greaser M. Improved methodology for analysis and quantification of proteins on one-dimensional silver-stained slab gels. Anal Biochem 129: 277-287, 1983.
19. Goodpaster BH, Park SW, Harris TB, Kritchevsky SB, Nevitt M, Schwartz AV, Simonsick EM, Tylavsky FA, Visser M, Newman AB. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 61: 1059-1064, 2006.
20. Haus JM, Carrithers JA, Trappe SW, Trappe TA. Collagen, crosslinking, and advanced glycation end products in aging human skeletal muscle. J Appl Physiol 103: 2068-2076, 2007.
21. Hersh EV, Moore PA, Ross GL. Over-the-counter analgesics and antipyretics: a critical assessment. Clin Ther 22: 500-548, 2000.
22. Hla T, Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 89: 7384-7388, 1992.
23. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 50: 889-896, 2002.
24. Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc 52: 80-85, 2004.
25. Jemiolo B, Trappe S. Single muscle fiber gene expression in human skeletal muscle: validation of internal control with exercise. Biochem Biophys Res Commun 320: 1043-1050, 2004.
26. Krentz JR, Quest B, Farthing JP, Quest DW, Chilibeck PD. The effects of ibuprofen on muscle hypertrophy, strength, and soreness during resistance training. Appl Physiol Nutr Metab 33: 470-475, 2008.
27. Liu YT, Kardosh A, Cooc J, Schonthal AH. Potential misidentification of cyclooxygenase-2 by Western blot analysis and prevention through the inclusion of appropriate controls. Mol Biotechnol 34: 329-335, 2006.
28. {increment}{increment}CT Method. Methods 25: 402-408, 2001.
29. Novak ML, Billich W, Smith SM, Sukhija KB, McLoughlin TJ, Hornberger TA, Koh TJ. COX-2 inhibitor reduces skeletal muscle hypertrophy in mice. Am J Physiol Regul Integr Comp Physiol 296: R1132-R1139, 2009.
30. O'Neill GP, Mancini JA, Kargman S, Yergey J, Kwan MY, Falgueyret JP, Abramovitz M, Kennedy BP, Ouellet M, Cromlish W, Culp S, Evans JF, Ford-Hutchinson AW, Vickers PJ. Overexpression of human prostaglandin G/H synthase-1 and-2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid. Mol Pharmacol 45: 245-254, 1994.
31. Otto JC, DeWitt DL, Smith WL. N-glycosylation of prostaglandin endoperoxide synthases-1 and-2 and their orientations in the endoplasmic reticulum. J Biol Chem 268: 18234-18242, 1993.
32. Palmer RM. Prostaglandins and the control of muscle protein synthesis and degradation. Prostaglandins Leukot Essent Fatty Acids 39: 95-104, 1990.
33. Percival MD, Ouellet M, Vincent CJ, Yergey JA, Kennedy BP, O'Neill GP. Purification and characterization of recombinant human cyclooxygenase-2. Arch Biochem Biophys 315: 111-118, 1994.
34. Phillips SM, Tipton KD, Aarsland A, Wolf SE, Wolfe RR. Mixed muscle protein synthesis and breakdown after resistance exercise in humans. Am J Physiol Endocrinol Metab 273: E99-E107, 1997.
35. Rainsford KD, Roberts SC, Brown S. Ibuprofen and paracetamol: relative safety in non-prescription dosages. J Pharm Pharmacol 49: 345-376, 1997.
36. Raue U, Slivka D, Jemiolo B, Hollon C, Trappe S. Proteolytic gene expression differs at rest and after resistance exercise between young and old women. J Gerontol A Biol Sci Med Sci 62: 1407-1412, 2007.
37. Rennie MJ, Wackerhage H, Spangenburg EE, Booth FW. Control of the size of the human muscle mass. Annu Rev Physiol 66: 799-828, 2004.
38. Rieu I, Magne H, Savary-Auzeloux I, Averous J, Bos C, Peyron MA, Combaret L, Dardevet D. Reduction of low grade inflammation restores blunting of postprandial muscle anabolism and limits sarcopenia in old rats. J Physiol 587: 5483-5492, 2009.
39. Rodemann HP, Goldberg AL. Arachidonic acid, prostaglandin E2 and F2α influence rates of protein turnover in skeletal and cardiac muscle. J Biol Chem 257: 1632-1638, 1982.
40. Roubenoff R, Castaneda C. Sarcopenia-understanding the dynamics of aging muscle. JAMA 286: 1230-1231, 2001.
41. Schneider C, Boeglin WE, Brash AR. Human cyclo-oxygenase-1 and an alternative splice variant: contrasts in expression of mRNA, protein and catalytic activities. Biochem J 385: 57-64, 2005.
42. Slivka D, Raue U, Hollon C, Minchev K, Trappe S. Single muscle fiber adaptations to resistance training in old (>80 yr) men: evidence for limited skeletal muscle plasticity. Am J Physiol Regul Integr Comp Physiol 295: R273-R280, 2008.
43. Soltow QA, Betters JL, Sellman JE, Lira VA, Long JH, Criswell DS. Ibuprofen inhibits skeletal muscle hypertrophy in rats. Med Sci Sports Exerc 38: 840-846, 2006.
44. Trappe S, Gallagher P, Harber M, Carrithers J, Fluckey J, Trappe T. Single muscle fibre contractile properties in young and old men and women. J Physiol 552: 47-58, 2003.
45. Trappe T, Raue U, Williams R, Carrithers J, Hickner R. Effects of age and resistance exercise on skeletal muscle interstitial prostaglandin F2α. Prostaglandins Leukot Essent Fatty Acids 74: 175-181, 2006.
46. Trappe T, Williams R, Carrithers J, Raue U, Esmarck B, Kjaer M, Hickner R. Influence of age and resistance exercise on human skeletal muscle proteolysis: a microdialysis approach. J Physiol 554: 803-813, 2004.
47. Trappe TA, Burd NA, Louis ES, Lee GA, Trappe SW. Influence of concurrent exercise or nutrition countermeasures on thigh and calf muscle size and function during 60 days of bed rest in women. Acta Physiol (Oxf) 191: 147-159, 2007.
48. 2 in response to eccentric resistance exercise: influence of ibuprofen and acetaminophen. J Clin Endocrinol Metab 86: 5067-5070, 2001.
49. Trappe TA, Lindquist DM, Carrithers JA. Muscle-specific atrophy of the quadriceps femoris with aging. J Appl Physiol 90: 2070-2074, 2001.
50. Trappe TA, White F, Lambert CP, Cesar D, Hellerstein M, Evans WJ. Effect of ibuprofen and acetaminophen on postexercise muscle protein synthesis. Am J Physiol Endocrinol Metab 282: E551-E556, 2002.
51. Visser M, Kritchevsky SB, Goodpaster BH, Newman AB, Nevitt M, Stamm E, Harris TB. Leg muscle mass and composition in relation to lower extremity performance in men and women aged 70 to 79: the health, aging and body composition study. J Am Geriatr Soc 50: 897-904, 2002.
52. Weinheimer EM, Jemiolo B, Carroll CC, Harber MP, Haus JM, Burd NA, Lemoine JK, Trappe SW, Trappe TA. Resistance exercise and cyclooxygenase (COX) expression in human skeletal muscle: implications for COX-inhibiting drugs and protein synthesis. Am J Physiol Regul Integr Comp Physiol 292: R2241-R2248, 2007.
53. Yarasheski KE, Pak-Loduca J, Hasten DL, Obert KA, Brown MB, Sinacore DR. Resistance exercise training increases mixed muscle protein synthesis rate in frail women and men ≥ 76 yr old. Am J Physiol Endocrinol Metab 277: E118-E125, 1999.